These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37763292)

  • 41. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
    Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
    J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.
    Al Yami MS; Silva MA; Donovan JL; Kanaan AO
    J Thromb Thrombolysis; 2018 Jan; 45(1):36-47. PubMed ID: 29043538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis.
    Vedovati MC; Giustozzi M; Bonitta G; Agnelli G; Becattini C
    Thromb Res; 2018 Oct; 170():175-180. PubMed ID: 30196195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis.
    Riaz IB; Fuentes H; Deng Y; Naqvi SAA; Yao X; Sangaralingham LR; Houghton DE; Padrnos LJ; Shamoun FE; Wysokinski WE; McBane RD
    JAMA Netw Open; 2023 Jul; 6(7):e2325283. PubMed ID: 37486628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges.
    Farge D; Frere C
    F1000Res; 2019; 8():. PubMed ID: 31297188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical controversies in the treatment of cancer-associated venous thromboembolism.
    Nachar VR; Schepers AJ
    J Oncol Pharm Pract; 2021 Jun; 27(4):939-953. PubMed ID: 33435819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oncologic Emergencies: Too Much Clotting-Venous Thromboembolism in Malignancy.
    Long B; Koyfman A
    J Emerg Med; 2019 Dec; 57(6):825-835. PubMed ID: 31627886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins.
    Smrke A; Gross PL
    Front Med (Lausanne); 2017; 4():142. PubMed ID: 28894738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.
    Vasanthamohan L; Boonyawat K; Chai-Adisaksopha C; Crowther M
    J Thromb Haemost; 2018 Jul; 16(7):1288-1295. PubMed ID: 29772108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis.
    Al Yami MS; Badreldin HA; Mohammed AH; Elmubark AM; Alzahrani MY; Alshehri AM
    J Thromb Thrombolysis; 2018 Aug; 46(2):145-153. PubMed ID: 29948754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and Efficacy of Direct Oral Anticoagulant Therapy in Patients With Cancer.
    Fovel LM; Seabury RW; Miller CD; Darko W; Probst LA; Horvath L
    J Pharm Pract; 2021 Oct; 34(5):710-714. PubMed ID: 31888399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study.
    Bang SM; Kang JH; Hong MH; Ahn JS; Oh SY; Baek JH; Choi YJ; Shin SH; Kim YJ; Gil HY; Park HE; Lee J; Park EL
    Clin Appl Thromb Hemost; 2021; 27():1076029620979575. PubMed ID: 33471574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.
    Shaw J; de Wit C; Le Gal G; Carrier M
    J Thromb Haemost; 2017 May; 15(5):925-930. PubMed ID: 28296069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
    Wang X; Ma Y; Hui X; Li M; Li J; Tian J; Wang Q; Yan P; Li J; Xie P; Yang K; Yao L
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010956. PubMed ID: 37058421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature.
    Nana P; Dakis K; Peroulis M; Rousas N; Spanos K; Kouvelos G; Arnaoutoglou E; Matsagkas M
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of Direct Oral Anticoagulants for Secondary Prevention of Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies.
    Wang Y; Lv H; Li D; Chen C; Gu G; Sun Y; Yang X; Liu Y; Fang F; Liu J; Tse G; Xia Y
    Front Pharmacol; 2019; 10():773. PubMed ID: 31354488
    [No Abstract]   [Full Text] [Related]  

  • 59. Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.
    Patel A; Williams H; Baer MR; Zimrin AB; Law JY
    Acta Haematol; 2019; 142(4):233-238. PubMed ID: 31108496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis.
    Rungjirajittranon T; Owattanapanich W; Chinthammitr Y; Ruchutrakool T; Suwanawiboon B
    Thromb J; 2022 Jul; 20(1):41. PubMed ID: 35902879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.